| 1 | Maturity-onset diabetes of the young, type 11 | Enrichment | BLK, FAM167A | 4.81 |
| 2 | Heart, malformation of | Enrichment | GATA4, MAPK1, TBX5 | 4.33 |
| 3 | Hepatocellular carcinoma | Enrichment | AXIN1, CTNNB1, TERT | 4.06 |
| 4 | Adrenocortical carcinoma | Enrichment | CTNNB1, TERT | 3.64 |
| 5 | Systemic lupus erythematosus | Enrichment | BLK, FCGR2A, FCGR2B | 3.31 |
| 6 | Adult hepatocellular carcinoma | Enrichment | AXIN1, CTNNB1 | 3.26 |
| 7 | Heart disease | Enrichment | GATA4, TBX5 | 2.86 |
| 8 | Patent foramen ovale | Enrichment | GATA4, TBX5 | 2.64 |
| 9 | Maturity-onset diabetes of the young | Enrichment | BLK, PDX1 | 2.55 |
| 10 | Hepatoblastoma | Enrichment | CTNNB1, TERT | 2.51 |
| 11 | Malaria | Enrichment | FCGR2A, FCGR2B | 2.43 |
| 12 | Keratolytic winter erythema | Enrichment | CTSB | 2.40 |
| 13 | Leprosy 3 | Enrichment | TLR2 | 2.40 |
| 14 | Pancreatic agenesis 1 | Enrichment | PDX1 | 2.40 |
| 15 | Maturity-onset diabetes of the young, type 4 | Enrichment | PDX1 | 2.40 |
| 16 | Noonan syndrome 5 | Enrichment | RAF1 | 2.40 |
| 17 | Holt-oram syndrome | Enrichment | TBX5 | 2.40 |
| 18 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 2.40 |
| 19 | Caudal duplication anomaly | Enrichment | AXIN1 | 2.40 |
| 20 | Ceroid lipofuscinosis, neuronal, 10 | Enrichment | CTSD | 2.40 |
| 21 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 2.40 |
| 22 | Retinitis pigmentosa 88 | Enrichment | RP1L1 | 2.40 |
| 23 | Noonan syndrome 13 | Enrichment | MAPK1 | 2.40 |
| 24 | Hoxha-aliu syndrome | Enrichment | ERI1 | 2.40 |
| 25 | Spastic paraplegia 13, autosomal dominant | Enrichment | HSPD1 | 2.40 |
| 26 | Ulnar/fibular ray defect and brachydactyly | Enrichment | RP1L1 | 2.40 |
| 27 | Atrial septal defect 2 | Enrichment | GATA4 | 2.40 |
| 28 | Leopard syndrome 2 | Enrichment | RAF1 | 2.40 |
| 29 | Occult macular dystrophy | Enrichment | RP1L1 | 2.40 |
| 30 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 2.40 |
| 31 | Macular degeneration, age-related, 10 | Enrichment | TLR4 | 2.40 |
| 32 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 2.40 |
| 33 | Reni syndrome | Enrichment | SGPL1 | 2.40 |
| 34 | Autosomal recessive dyskeratosis congenita 4 | Enrichment | TERT | 2.40 |
| 35 | Trigonitis | Enrichment | RAF1 | 2.40 |
| 36 | Craniometadiaphyseal osteosclerosis with hip dysplasia | Enrichment | AXIN1 | 2.40 |
| 37 | Ulnar/fibula ray defect-brachydactyly syndrome | Enrichment | RP1L1 | 2.40 |
| 38 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 2.40 |
| 39 | Spondyloepimetaphyseal dysplasia, guo-campeau type | Enrichment | ERI1 | 2.40 |
| 40 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 2.40 |
| 41 | Microcystic stromal tumor | Enrichment | CTNNB1 | 2.40 |
| 42 | Bladder cancer | Enrichment | CTNNB1, TERT | 2.23 |
| 43 | Pancreas, dorsal, agenesis of | Enrichment | PDX1 | 2.10 |
| 44 | Thumb deformity | Enrichment | TBX5 | 2.10 |
| 45 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 2.10 |
| 46 | Leukodystrophy, hypomyelinating, 4 | Enrichment | HSPD1 | 2.10 |
| 47 | Peeling skin syndrome 2 | Enrichment | CSTA | 2.10 |
| 48 | Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 1 | Enrichment | TERT | 2.10 |
| 49 | Osteogenesis imperfecta, type xiii | Enrichment | BMP1 | 2.10 |
| 50 | Squalene synthase deficiency | Enrichment | FDFT1 | 2.10 |
| 51 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 2.10 |
| 52 | 46,xy sex reversal 3 | Enrichment | GATA4 | 2.10 |
| 53 | Melanoma, cutaneous malignant 9 | Enrichment | TERT | 2.10 |
| 54 | Aortic valve disease 2 | Enrichment | TBX5 | 2.10 |
| 55 | Idiopathic interstitial pneumonia | Enrichment | TERT | 2.10 |
| 56 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 2.10 |
| 57 | Teratoma | Enrichment | CTNNB1 | 2.10 |
| 58 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.92 |
| 59 | Peeling skin syndrome 4 | Enrichment | CSTA | 1.92 |
| 60 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.92 |
| 61 | Anus, imperforate | Enrichment | CTNNB1 | 1.92 |
| 62 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.92 |
| 63 | Desmoid tumor | Enrichment | CTNNB1 | 1.92 |
| 64 | Interstitial lung disease | Enrichment | TERT | 1.92 |
| 65 | Macrocytic anemia | Enrichment | TERT | 1.92 |
| 66 | High bone mass osteogenesis imperfecta | Enrichment | BMP1 | 1.92 |
| 67 | Type 2 diabetes mellitus | Enrichment | PDX1, SLC2A4 | 1.92 |
| 68 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.80 |
| 69 | Pilomatrixoma | Enrichment | CTNNB1 | 1.80 |
| 70 | Alazami syndrome | Enrichment | CTNNB1 | 1.80 |
| 71 | Lung sarcomatoid carcinoma | Enrichment | TERT | 1.80 |
| 72 | Craniopharyngioma | Enrichment | CTNNB1 | 1.80 |
| 73 | Noonan syndrome with multiple lentigines | Enrichment | RAF1 | 1.80 |
| 74 | Mitral valve insufficiency | Enrichment | TBX5 | 1.80 |
| 75 | Transposition of the great arteries | Enrichment | GATA4 | 1.80 |
| 76 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 1.70 |
| 77 | Atrioventricular septal defect | Enrichment | TBX5 | 1.70 |
| 78 | Ventricular septal defect 1 | Enrichment | GATA4 | 1.70 |
| 79 | Congenital heart defects, multiple types, 4 | Enrichment | GATA4 | 1.70 |
| 80 | Idiopathic aplastic anemia | Enrichment | TERT | 1.70 |
| 81 | Atrial septal defect 1 | Enrichment | TBX5 | 1.63 |
| 82 | Dyskeratosis congenita, autosomal dominant 1 | Enrichment | TERT | 1.63 |
| 83 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.63 |
| 84 | Pulmonary fibrosis | Enrichment | TERT | 1.63 |
| 85 | Hoyeraal-hreidarsson syndrome | Enrichment | TERT | 1.63 |
| 86 | Kidney clear cell sarcoma | Enrichment | TERT | 1.63 |
| 87 | Noonan syndrome 3 | Enrichment | RAF1 | 1.56 |
| 88 | Dyskeratosis congenita, autosomal dominant 2 | Enrichment | TERT | 1.56 |
| 89 | Gallbladder cancer | Enrichment | CTNNB1 | 1.56 |
| 90 | Pilomyxoid astrocytoma | Enrichment | RAF1 | 1.56 |
| 91 | Melanocytic nevus syndrome, congenital | Enrichment | RAF1 | 1.50 |
| 92 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.50 |
| 93 | Permanent neonatal diabetes mellitus | Enrichment | PDX1 | 1.50 |
| 94 | Ventricular septal defect | Enrichment | TBX5 | 1.45 |
| 95 | Aplastic anemia | Enrichment | TERT | 1.41 |
| 96 | Dilated cardiomyopathy | Enrichment | RAF1, TBX5 | 1.39 |
| 97 | Atrial heart septal defect | Enrichment | TBX5 | 1.37 |
| 98 | Interatrial communication | Enrichment | TBX5 | 1.37 |
| 99 | Specific learning disability | Enrichment | MAPK1 | 1.37 |
| 100 | Renal hypodysplasia/aplasia 3 | Enrichment | ERI1 | 1.33 |
| 101 | Meningioma | Enrichment | TERT | 1.33 |
| 102 | Colorectal cancer | Enrichment | CTNNB1, TLR2 | 1.33 |
| 103 | Acute promyelocytic leukemia | Enrichment | NUMA1 | 1.30 |
| 104 | Medulloblastoma | Enrichment | CTNNB1 | 1.26 |
| 105 | Aortic aneurysm, familial thoracic 1 | Enrichment | GATA4 | 1.26 |
| 106 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4 | 1.26 |
| 107 | Osteogenesis imperfecta, type iii | Enrichment | BMP1 | 1.24 |
| 108 | Neuronal ceroid lipofuscinosis | Enrichment | CTSD | 1.24 |
| 109 | Noonan syndrome and noonan-related syndrome | Enrichment | RAF1 | 1.24 |
| 110 | Melanoma, cutaneous malignant 1 | Enrichment | TERT | 1.18 |
| 111 | Interstitial lung disease 2 | Enrichment | TERT | 1.18 |
| 112 | Polycystic liver disease | Enrichment | CTNNB1 | 1.18 |
| 113 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 1.18 |
| 114 | Behcet syndrome | Enrichment | TLR4 | 1.14 |
| 115 | Dyskeratosis congenita | Enrichment | TERT | 1.14 |
| 116 | Leukodystrophy | Enrichment | HSPD1 | 1.12 |
| 117 | Microcephaly | Enrichment | CTNNB1, MAPK1 | 1.07 |
| 118 | Noonan syndrome 1 | Enrichment | RAF1 | 1.06 |
| 119 | Brittle bone disorder | Enrichment | BMP1 | 1.06 |
| 120 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | RAF1 | 1.04 |
| 121 | Familial atrial fibrillation | Enrichment | GATA4 | 1.04 |
| 122 | Tetralogy of fallot | Enrichment | GATA4 | 1.01 |
| 123 | Rasopathy | Enrichment | RAF1 | 1.01 |
| 124 | Differentiated thyroid carcinoma | Enrichment | TERT | 0.96 |
| 125 | Long qt syndrome 1 | Enrichment | TBX5 | 0.95 |
| 126 | Cystic fibrosis | Enrichment | FCGR2A | 0.92 |
| 127 | Familial hypertrophic cardiomyopathy | Enrichment | RAF1 | 0.91 |
| 128 | Left ventricular noncompaction | Enrichment | RAF1 | 0.88 |
| 129 | Leukemia, acute myeloid | Enrichment | TERT | 0.83 |
| 130 | Nephrotic syndrome | Enrichment | SGPL1 | 0.80 |
| 131 | Optic atrophy plus syndrome | Enrichment | RP1L1 | 0.79 |
| 132 | Familial isolated dilated cardiomyopathy | Enrichment | RAF1 | 0.72 |
| 133 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | GATA4 | 0.70 |
| 134 | Schizophrenia | Enrichment | MSRA | 0.68 |
| 135 | Ovarian cancer | Enrichment | CTNNB1 | 0.48 |
| 136 | Congenital nervous system abnormality | Enrichment | CTNNB1 | 0.46 |
| 137 | Nervous system disease | Enrichment | CTNNB1 | 0.46 |
| 138 | Retinitis pigmentosa | Enrichment | RP1L1 | 0.24 |
| 139 | Hereditary retinal dystrophy | Enrichment | RP1L1 | 0.16 |
| 140 | Fundus dystrophy | Enrichment | RP1L1 | 0.16 |